The BEL is part of the BEL Company (BEL Co) which was formed in 2017 to continue basic research on the human brain and cognition as well as to develop new neuroscience technologies with grant funding, including from the US Small Business Innovation Research (SBIR) program. The BEL was formerly associated with EGI, which has now been acquired by Philips Neuro (www.egi.com). For two SBIR projects that Philips has released to BEL Co (one on next generation neuromodulation or GTEN technology and one on MR-compatible EEG technology), Philips has received a right of first refusal to products and technology arising from the grant. Otherwise, BEL Co is fully independent from Philips or any other large business.
Every part of this theme can be translated to another language. Even this content you are reading now!
The drop-down in the main menu is called a Locale Picker. It lets you quickly switch between any of the available languages when browsing this website.
For help on setting up more languages, close this popup and click the Languages menu item.